Nephros (NASDAQ:NEPH) Stock Price Down 0.7%

Nephros, Inc. (NASDAQ:NEPHGet Free Report) traded down 0.7% on Friday . The stock traded as low as $1.83 and last traded at $1.86. 1,071 shares traded hands during mid-day trading, a decline of 93% from the average session volume of 15,634 shares. The stock had previously closed at $1.87.

Nephros Stock Down 0.7 %

The firm has a market cap of $19.63 million, a PE ratio of -13.30 and a beta of 1.19. The firm has a 50-day moving average price of $2.01 and a two-hundred day moving average price of $2.17.

Nephros (NASDAQ:NEPHGet Free Report) last released its earnings results on Thursday, August 8th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.02). The firm had revenue of $3.25 million during the quarter. Nephros had a negative net margin of 9.40% and a negative return on equity of 15.64%.

Hedge Funds Weigh In On Nephros

An institutional investor recently bought a new position in Nephros stock. Mesirow Financial Investment Management Inc. acquired a new position in shares of Nephros, Inc. (NASDAQ:NEPHFree Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 15,383 shares of the company’s stock, valued at approximately $34,000. Mesirow Financial Investment Management Inc. owned approximately 0.15% of Nephros as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 41.10% of the company’s stock.

Nephros Company Profile

(Get Free Report)

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.

Featured Stories

Receive News & Ratings for Nephros Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nephros and related companies with MarketBeat.com's FREE daily email newsletter.